ASH 2018 | Waldenström’s macroglobulinemia: a link between institution visited and survival

Stephen Ansell

Waldenström macroglobulinemia (WM) is a rare B-cell malignancy, and practicing hematologists and oncologists may rarely treat these patients. Here, Stephen Ansell, MD, PhD, of the Mayo Clinic, Rochester, MI, raises the question: does a patient’s outcome depend on the institution visited? Speaking at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, Prof. Ansell reveals a correlation between these factors, before stressing the importance of seeking out expertise and going to a center that sees a lot of patients.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter